Biotech Startups

C&C International develops cosmetic and beauty products through dedicated makeup and skincare research laboratories, serving the beauty industry.

1 investor

Coagulo develops a portable point-of-care testing platform for coagulation disorder diagnosis and management using microfluidic technology and data analytics. The platform enables healthcare providers to perform comprehensive coagulation testing with drops of blood and deliver results within 10 minutes.

1 investor

CoapTech makes the PUMA-G System, an FDA-cleared ultrasound-based device for bedside feeding tube (gastrostomy) placement, used in ICUs, step-down units, IR suites, and long-term acute care hospitals. The system aims to reduce hospital costs, procedure risks, and ICU/hospital length of stay compared to conventional PEG or PRG procedures.

1 investor

Coastar Therapeutics develops gene delivery technologies using erythrocyte-derived membranes to enable genetic medicines for cancer immunotherapy and gene therapies. The company works with pharmaceutical and biotech partners to deliver therapeutics with improved immune evasion and precision targeting.

1 investor

Coastline Bio is a biopharmaceutical company developing novel medicines for immunological skin diseases, with an initial focus on atopic dermatitis. The company is developing a first-in-class monoclonal antibody targeting disease pathways in skin conditions.

1 investor

1 investor

Cocuus develops production technology for the food industry, with a focus on meat processing, to create nutritious and sustainable food products.

1 investor

Code Biotherapeutics develops a proprietary non-viral 3DNA delivery platform for genetic medicines, RNAi, and other modalities, using targeting molecules to reach specific cells and tissues outside the liver. The platform is designed for re-dosing, delivery of large gene constructs approaching 10kb, and modular manufacturing for genetic medicine development.

1 investor

Codexis provides enzyme engineering and biocatalysis services for RNA and small molecule API manufacturing, offering RNAi/siRNA and enzymatic synthesis solutions to pharmaceutical partners. It supports customers from process development through scalable commercial supply using an in-house pilot plant and CMO network.

1 investor

Cognigenics is developing iRNAi, a non-invasive intranasal RNA interference platform that delivers programmable RNA therapeutics directly to targeted brain circuits, bypassing the blood-brain barrier to modulate mood, memory, and cognition. The company focuses on precision neuropsychiatry and treatments for neurological and psychiatric disorders.

1 investor

Avacare Clinical Research Network operates a centralized clinical trial network that connects sponsors, research sites, and patients for clinical trials. It provides research-experienced investigators, data-driven operations, and site support tools, along with a patient platform for finding and enrolling in open studies.

1 investor

Cognoptix develops the Sapphire II system, a non-invasive laser eye scanning device paired with an eye ointment that binds to beta amyloid proteins in the lens of the eye to aid early detection and diagnosis of Alzheimer's disease. The company builds diagnostic devices and agents for clinical, commercial, and academic research use and works with pharma partners and academic institutes.

1 investor

Cogstate provides digital cognitive assessments, electronic clinical outcome assessment (eCOA) support, and endpoint data quality services for biopharmaceutical companies, academic institutions, and clinicians. Founded in 1999, it also supplies cognitive testing tools used in sports medicine and clinical trials for neurological and psychiatric conditions.

1 investor

Coherence Bio makes Keystone, a benchtop laboratory instrument that integrates cell culture, fluid handling, scheduled interventions, and multimodal imaging into a single uninterrupted multi-day run. It is aimed at research labs running organoid, spheroid, and other multi-day cell biology protocols such as longitudinal phenotyping and drug response kinetics.

1 investor

Coherent Biopharma (Tongyi Pharmaceutical) is a biopharmaceutical company developing its proprietary Bi-targeting XDC (bi-XDC) conjugate drug platform to make previously undruggable targets treatable, with a focus on oncology. It has a pipeline of first-in-class candidates and clinical trials across multiple cancer indications, operating in China, the U.S., and Australia.

1 investor

CollimateHealth develops a clinically scalable microbeam radiation technology for cancer treatment, delivering arrays of narrow, micrometer-scale radiation beams at higher doses than conventional broad-beam radiation oncology. The technology aims to trigger immune responses against cancer cells and improve delivery of chemotherapy and immunotherapy into tumor tissue.

1 investor

1 investor

1 investor

Commit Biologics develops a complement-targeted drug discovery platform and antibody-based therapeutics for oncology, autoimmune diseases, and infectious disease indications. The company combines structural biology and complement research to advance novel therapeutic programs.

1 investor

CompagOs develops Bon3OID, a biohardware platform that combines 3D bioprinted bone-like tissue constructs with hardware for controlled mechanical loading to produce functional readouts of bone remodeling. It serves preclinical drug development and translational diagnostics as a human-relevant in-vitro alternative to animal models for bone-focused research.

1 investor

Complete Omics develops a clinical proteomics platform that identifies patient-specific neoantigens to enable personalized cancer therapeutics. The platform guides the design of targeted treatments such as mRNA vaccines and cell therapies.

1 investor

Complyit is a specialist consulting firm in the life sciences sector, providing services such as project management, quality assurance, and validation for the pharmaceutical and medical technology industries. It supplies experienced consultants to companies with high requirements on staff knowledge and expertise.

1 investor

A blood bank and laboratory services provider supplying blood products including red blood cells, plasma, and platelets to hospitals and medical facilities, alongside laboratory testing services and specialty clinical procedures. Serves medical institutions, research facilities, and pharmaceutical companies nationally.

1 investor

Compugen develops immuno-oncology therapeutics using Unigen, a computational platform that combines scientific research with AI/ML to identify novel drug targets and design first-in-class antibody drugs. Its therapeutic antibodies targeting novel pathways are being evaluated in multiple clinical trials.

1 investor